Skip to main content
Premium Trial:

Request an Annual Quote

Allscripts Makes $200M Investment in NantHealth

NEW YORK (GenomeWeb) – Allscripts today announced it has acquired a 10 percent stake in informatics firm NantHealth for $200 million in cash.

NantCapital, an investment firm associated with NantHealth founder Patrick Soon-Shiong, has also invested $100 million in Allscripts. The investments follow an alliance between the firms, announced in March 2015, to integrate NantHealth's Genomic Proteomic Sequencing (GPS Cancer) diagnostic test and Eviti treatment protocol planning tool into Allscripts' electronic medical record and practice management software.

The firms said they will jointly develop application programming interfaces (APIs) between their systems as well as integrate NantTransporter, NantCancer Genome Browser, NantContraster, Paradigm, and GPS Cancer sequencing invitations with the Allscripts platform.

NantCapital's investment has been executed through a private placement of Allscripts common stock, the firm said. Allscripts received gross proceeds of approximately $100 million and said the transaction does not change its 2015 guidance.